“Yesterday (Thursday), the European Commission authorized the first two variant-targeted covid-19 booster vaccines from BioNTech-Pfizer and Moderna based on positive opinions from the EMA,” Kyriakides said, adding that more vaccines should be approved soon .
The modified vaccines target both the original virus variant and the BA.1 omicron variant. Vaccines targeting the BA.4 and BA.5 submutations of the omicron coronavirus variant, which are now dominant and more infectious, are currently under review by the EMA.
According to the World Health Organization (WHO), the BA.5 subvariant now accounts for up to 80 percent of covid-19 cases worldwide.
The European Medicines Agency has recommended the approval of two omicron vaccines
The EU regulator has recommended the administration of booster doses to persons aged 12 and over who have received at least a basic vaccination against the covid-19 disease in the past.
Vaccines by Pfizer/BioNTech and Moderna, which target the omikron variant of the coronavirus, were already approved by the US Food and Drug Administration (FDA) on Wednesday.
In mid-August, the modified vaccination from Moderna was also approved by the British Medicines Authority MHRA.
Britain has approved the first vaccine against two variants of the coronavirus